Alaa Elbendary, M.D.

5.3 times the Medicare Part D claims of the average gynecologic oncology physician in 2024

1,049 Medicare Part D claims for 139 beneficiaries, against an average of 198 among the 1,016 providers of this specialty who prescribed in Part D. 51 claims were for opioids.

Most prescribed

1. Warfarin Sodium174 claims
2. Ondansetron Hcl60 claims
3. Oxycodone-Acetaminophen51 claims
4. Letrozole44 claims
5. Prochlorperazine Maleate42 claims
6. Megestrol Acetate41 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's Medicare quality score for 2023: 71.9 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $1,107.67

43 payments, mostly food and beverage; the largest payer was GlaxoSmithKline, LLC.. The 833 providers of this specialty with any payment received $6,785.12 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

One hospital or facility affiliation

1. Midwest Oncology Associates LLCOverland Park, KS

Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.